Mahamaya Lifesciences IPO is to open on November 11, 2025. It is a SME IPO that will raise ₹70.44 crores. The Mahamaya Lifesciences IPO price band is fixed at ₹108 to ₹114 with a market lot of 2,400 Shares.
Mahamaya Lifesciences IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | GMP Trend | Gain |
| 18 Nov | ₹- | – | -% |
Mahamaya Lifesciences IPO Details
| IPO Open Date | November 11, 2025 |
| IPO Close Date | November 13, 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹108 to ₹114 Per Share |
| Issue Size | Approx ₹70.44 Crores |
| Fresh Issue | Approx ₹64.28 Crores |
| Offer for Sale: | Approx 5,40,000 Equity Shares |
| Issue Type | Book Built Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Mahamaya Lifesciences IPO Dates
| IPO Open Date: | November 11, 2025 |
| IPO Close Date: | November 13, 2025 |
| Basis of Allotment: | November 14, 2025 |
| Refunds: | November 17, 2025 |
| Credit to Demat Account: | November 17, 2025 |
| IPO Listing Date: | November 18, 2025 |
| IPO Bidding Cut-off Time: | November 13, 2025 – 5 PM |
Business Overview
Mahamaya Lifesciences Limited, founded in 2002, is one of the leading companies that focuses on the manufacturing of pesticide formulations and supplies bulk formulations. By working with the Central Insecticides Board and Registration Committee (CIBRC), the company started its business with the import and registration of major pesticide molecules that were not produced in India. After successful registration, they decided to market these molecules as technical products to both Indian agrochemical companies as well as multinational corporations (MNCs).
Since its incorporation in 2002, the company has grown significantly by setting up its own manufacturing plant in December 2021 at Dahej, Gujarat. Its product has reached various states like Punjab, Haryana, Rajasthan, Uttar Pradesh, Gujarat, Maharashtra, Andhra Pradesh, and Telangana in India, while internationally they export their products to Turkey, Egypt, and the UAE.
Mahamaya Lifesciences IPO GMP aka Grey Market Premium FAQs:
What is Mahamaya Lifesciences IPO GMP Today?
What is Mahamaya Lifesciences IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Mahamaya Lifesciences IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
